117 related articles for article (PubMed ID: 21476603)
1. Mannosylated dextran nanoparticles: a pH-sensitive system engineered for immunomodulation through mannose targeting.
Cui L; Cohen JA; Broaders KE; Beaudette TT; Fréchet JM
Bioconjug Chem; 2011 May; 22(5):949-57. PubMed ID: 21476603
[TBL] [Abstract][Full Text] [Related]
2. Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
Carrillo-Conde B; Song EH; Chavez-Santoscoy A; Phanse Y; Ramer-Tait AE; Pohl NL; Wannemuehler MJ; Bellaire BH; Narasimhan B
Mol Pharm; 2011 Oct; 8(5):1877-86. PubMed ID: 21882825
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
Adams EW; Ratner DM; Seeberger PH; Hacohen N
Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
[TBL] [Abstract][Full Text] [Related]
4. Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells.
Tan MC; Mommaas AM; Drijfhout JW; Jordens R; Onderwater JJ; Verwoerd D; Mulder AA; van der Heiden AN; Ottenhoff TH; Cella M; Tulp A; Neefjes JJ; Koning F
Adv Exp Med Biol; 1997; 417():171-4. PubMed ID: 9286356
[TBL] [Abstract][Full Text] [Related]
5. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
[TBL] [Abstract][Full Text] [Related]
6. Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation.
Wang C; Li P; Liu L; Pan H; Li H; Cai L; Ma Y
Biomaterials; 2016 Feb; 79():88-100. PubMed ID: 26702587
[TBL] [Abstract][Full Text] [Related]
7. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
9. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
10. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.
White KL; Rades T; Furneaux RH; Tyler PC; Hook S
J Pharm Pharmacol; 2006 Jun; 58(6):729-37. PubMed ID: 16734974
[TBL] [Abstract][Full Text] [Related]
11. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
Cruz LJ; Tacken PJ; Fokkink R; Joosten B; Stuart MC; Albericio F; Torensma R; Figdor CG
J Control Release; 2010 Jun; 144(2):118-26. PubMed ID: 20156497
[TBL] [Abstract][Full Text] [Related]
12. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
[TBL] [Abstract][Full Text] [Related]
13. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents.
Tiwari S
Crit Rev Ther Drug Carrier Syst; 2018; 35(2):157-194. PubMed ID: 29717665
[TBL] [Abstract][Full Text] [Related]
15. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
[TBL] [Abstract][Full Text] [Related]
16. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.
Vela Ramirez JE; Roychoudhury R; Habte HH; Cho MW; Pohl NL; Narasimhan B
J Biomater Sci Polym Ed; 2014; 25(13):1387-406. PubMed ID: 25068589
[TBL] [Abstract][Full Text] [Related]
18. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Pohl NL; Narasimhan B; Wannemuehler MJ; Bellaire BH
Acta Biomater; 2013 Nov; 9(11):8902-9. PubMed ID: 23796408
[TBL] [Abstract][Full Text] [Related]
19. pH-Degradable Mannosylated Nanogels for Dendritic Cell Targeting.
De Coen R; Vanparijs N; Risseeuw MD; Lybaert L; Louage B; De Koker S; Kumar V; Grooten J; Taylor L; Ayres N; Van Calenbergh S; Nuhn L; De Geest BG
Biomacromolecules; 2016 Jul; 17(7):2479-88. PubMed ID: 27231045
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
